Global Glaucoma and Cataract Surgery Devices Market Size By Type (Glaucoma Surgery Device, Cataract Surgery Device), By Application (Hospital, Ophthalmology Clinic), By Region, And Segment Forecasts,...

The Global Glaucoma and Cataract Surgery Devices Market was valued at USD 5.1 billion in 2023 and is projected to surpass USD 9.4 billion by 2031, growing at a CAGR of 7.9% during the forecast period of 2023–2031. This growth is driven by the increasing prevalence of age-related ophthalmic disorders, advancements in surgical technology, and rising awareness of early diagnosis and treatment. The global aging population, which is more prone to eye conditions such as glaucoma and cataracts, is significantly boosting the demand for effective surgical interventions.

Drivers:

Rising Incidence of Ophthalmic Disorders:

The global burden of visual impairments, especially glaucoma and cataracts, is steadily increasing due to aging populations and lifestyle changes. This has resulted in greater demand for surgical treatment and innovative devices.

Technological Advancements in Surgical Equipment:

Innovations such as femtosecond lasers, micro-invasive glaucoma surgery (MIGS) devices, and AI-assisted diagnostics are improving surgical outcomes, boosting adoption among ophthalmologists.

Government and Non-Profit Initiatives:

Efforts by governments and NGOs to provide accessible eye care, especially in developing regions, are increasing the demand for cost-effective surgical solutions and devices.

Restraints:

High Cost of Advanced Surgical Devices:

While technology enhances surgical precision, the high cost of advanced devices can limit their adoption in lower-income and rural healthcare settings.

Lack of Skilled Professionals in Developing Regions:

A shortage of trained ophthalmic surgeons, particularly in underdeveloped areas, limits the widespread implementation of modern surgical procedures.

Opportunity:

Rising Investments in Healthcare Infrastructure:

Developing countries are witnessing substantial improvements in healthcare facilities, offering lucrative opportunities for manufacturers of glaucoma and cataract surgery devices.

Growing Demand for Minimally Invasive Surgeries:

Patients are increasingly opting for minimally invasive solutions due to shorter recovery times, lower risks, and improved outcomes—creating room for innovation and market growth.

Market by System Type Insights:

Based on system type, the Cataract Surgery Devices segment held the largest market share in 2023. The widespread use of intraocular lenses (IOLs), phacoemulsification equipment, and femtosecond lasers has driven this segment’s dominance. The Glaucoma Surgery Devices segment, particularly MIGS, is projected to witness the fastest growth due to safer profiles and effective long-term pressure control.

Market by End-use Insights:

The Hospitals & Specialty Clinics segment accounted for the majority of the market in 2023. These facilities are often equipped with advanced technologies and staffed with skilled surgeons, making them the preferred choice for ophthalmic procedures. The Ambulatory Surgical Centers (ASCs) segment is also growing rapidly due to shorter procedure times and reduced healthcare costs.

Market by Regional Insights:

North America dominated the market in 2023, driven by high healthcare spending, advanced medical technologies, and widespread awareness. Asia-Pacific is expected to be the fastest-growing region due to a rapidly aging population, increasing healthcare access, and rising government initiatives for vision care in countries like China and India.

Competitive Scenario:

Key players in the market include Alcon Inc., Johnson & Johnson Vision, Bausch + Lomb, Glaukos Corporation, Carl Zeiss Meditec AG, Ellex Medical Lasers, STAAR Surgical Company, and Santen Pharmaceutical Co., Ltd. These companies focus on innovation, strategic collaborations, and product development to enhance their global market presence.

Scope of Work – Global Glaucoma and Cataract Surgery Devices Market

Report Metric Details

Market Size (2023) USD 5.1 billion

Projected Market Size (2031) USD 9.4 billion

CAGR (2023–2031) 7.9%

Market Segments By System Type (Cataract Devices, Glaucoma Devices), End-use, Region

Growth Drivers Aging Population, Technological Advancements, Government Vision Initiatives

Opportunities Minimally Invasive Devices, Healthcare Investment in Emerging Markets

Key Market Developments:

2023: Alcon launched a next-generation femtosecond laser platform for cataract surgery, enabling greater precision and shorter recovery.

2024: Glaukos received expanded FDA approval for its MIGS device, enhancing its use in combination cataract and glaucoma surgeries.

2025: Johnson & Johnson Vision announced a new suite of customizable IOLs targeting varying patient visual needs post-cataract surgery.

FAQs:

What is the current market size of